Bloomberg Quotes Michael Carome on FDA Authorization of COVID-19 Plasma Treatments

By Cristin Flanagan

“’Such action seriously damages the FDA’s credibility during the greatest public health crisis in 100 years,’ Michael Carome, health research group director at the consumer advocacy group Public Citizen said in a statement. ‘This does not bode well for future FDA decisions regarding COVID-19 vaccines and therapeutics between now and election day.”‘

Read the full story here.